No black box warning on record for Femring

As of the latest FDA labeling reviewed, Femring (ESTRADIOL ACETATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Femring medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Femring is used only in the vagina, however, the risks associated with oral estrogens should be taken into account. • Estrogens increase the risk of gallbladder disease ( 5.4 ) • Discontinue estrogen if severe hypercalcemia, loss of vision, severe hypertriglyceridemia or cholestatic jaundice occurs ( 5.5 , 5.6 , 5.9 , 5.10 ) • Monitor thyroid function in women on thyroid

No black box warning on record for Femring

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Femring is used only in the vagina, however, the risks associated with oral estrogens should be taken into account. • Estrogens increase the risk of gallbladder disease ( 5.4 ) • Discontinue estrogen if severe hypercalcemia, loss of vision, severe hypertriglyceridemia or cholestatic jaundice occurs ( 5.5 , 5.6 , 5.9 , 5.10 ) • Monitor thyroid function in women on thyroid

Femring Black Box Warning

No black box warning on record for Femring

Other warnings & precautions

Femring Black Box Warning

No black box warning on record for Femring

Other warnings & precautions